DeVinney Erick Wayne (CIK 0001595972)

Latest company ownership

AXGN - Axogen, Inc.
Role: Chief Innovation Officer
Shares held
220,649
Last filed at
Dec 5, 2025
Confidence Score
46.0
2025Q4
Confidence Score History
2018Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 9, 2025 Dec 10, 2025 Axogen, Inc. Chief Innovation Officer Sell 40.0 -19,517 -7.49% ✗ $609.1K
Sep 13, 2025 Sep 16, 2025 Axogen, Inc. Chief Innovation Officer Sell 68.8 +1,363 0.62% ✗ $18.5K
Mar 16, 2025 Mar 19, 2025 Axogen, Inc. Chief Innovation Officer Sell 40.0 -15,111 -6.49% ✗ $264.4K
Feb 28, 2025 Mar 4, 2025 Axogen, Inc. Chief Innovation Officer Sell 42.5 -8,296 -3.96% ✗ $152.2K
Feb 22, 2025 Feb 26, 2025 Axogen, Inc. Chief Innovation Officer Sell 68.8 +1,528 0.84% ✗ $16K
Mar 16, 2024 Mar 25, 2024 Axogen, Inc. Chief Innovation Officer Sell 48.8 -4,578 -0.89% ✗ $35.2K
Jul 18, 2023 Oct 13, 2023 Axogen, Inc. VP Peripheral Nerve Science Sell 67.5 +715 0.63% ✗ $3.5K
Mar 16, 2023 Mar 20, 2023 Axogen, Inc. VP Peripheral Nerve Science Sell 46.3 -2,769 -1.23% ✗ $22.9K
Dec 27, 2022 Dec 29, 2022 Axogen, Inc. VP Peripheral Nerve Science Sell 52.5 -187 -0.18% ✗ $1.8K
Dec 27, 2022 Dec 28, 2022 Axogen, Inc. VP Peripheral Nerve Science Sell 22.5 -10,784 -9.24% ✗ $101.8K
Jul 18, 2022 Jul 20, 2022 Axogen, Inc. VP Peripheral Nerve Science Sell 67.5 +1,174 0.62% ✗ $3.4K
Mar 16, 2022 Mar 18, 2022 Axogen, Inc. VP Peripheral Nerve Science Sell 46.3 -1,497 -1.59% ✗ $11.9K
Feb 15, 2022 Feb 17, 2022 Axogen, Inc. VP Peripheral Nerve Science Sell 67.5 +824 0.94% ✗ $3K
Dec 27, 2021 Dec 29, 2021 Axogen, Inc. VP Peripheral Nerve Science Sell 52.5 -187 -0.21% ✗ $1.8K
Dec 20, 2021 Dec 22, 2021 Axogen, Inc. VP Peripheral Nerve Science Sell 52.5 -144 -0.17% ✗ $1.3K
Dec 15, 2021 Dec 17, 2021 Axogen, Inc. VP Peripheral Nerve Science Sell 26.3 -4,171 -4.61% ✗ $36.7K
Jul 19, 2021 Jul 21, 2021 Axogen, Inc. VP Peripheral Nerve Science Sell 77.5 +1,188 1.50% ✗ $7.5K
Feb 16, 2021 Feb 18, 2021 Axogen, Inc. VP, Clinical&Translational Sc Sell 78.8 +4,367 1.63% ✗ $34.9K
Dec 27, 2020 Dec 30, 2020 Axogen, Inc. VP, Clinical&Translational Sc Sell 77.5 +1,129 1.82% ✗ $6.6K
Dec 18, 2020 Dec 22, 2020 Axogen, Inc. VP, Clinical&Translational Sc Sell 67.5 +428 0.69% ✗ $2.4K
Dec 15, 2020 Dec 17, 2020 Axogen, Inc. VP, Clinical&Translational Sc Sell 22.5 -4,373 -6.62% ✗ $72.2K
Feb 18, 2020 Feb 20, 2020 Axogen, Inc. VP, Clinical&Translational Sc Sell 86.3 +4,381 9.92% ✗ $27.1K
Dec 18, 2019 Dec 20, 2019 Axogen, Inc. VP, Clinical&Translational Sc Sell 77.5 +869 2.07% ✗ $4.7K
Feb 15, 2019 Feb 19, 2019 Axogen, Inc. VP, Clinical&Translational Sc Sell 86.3 +3,581 9.33% ✗ $26.3K
Nov 13, 2018 Nov 15, 2018 Axogen, Inc. VP, Clinical&Translational Sc Sell 22.5 -2,882 -7.20% ✗ $95.9K